Cellectar Biosciences Inc (CLRB)
2.035
-0.01
(-0.49%)
USD |
NASDAQ |
Oct 31, 16:00
2.035
0.00 (0.00%)
After-Hours: 19:18
Cellectar Biosciences Cash from Operations (TTM): -45.17M for June 30, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2024 | -45.17M |
March 31, 2024 | -38.55M |
December 31, 2023 | -32.38M |
September 30, 2023 | -30.19M |
June 30, 2023 | -29.14M |
March 31, 2023 | -27.37M |
December 31, 2022 | -25.22M |
September 30, 2022 | -22.32M |
June 30, 2022 | -21.74M |
March 31, 2022 | -22.86M |
December 31, 2021 | -22.57M |
September 30, 2021 | -21.93M |
June 30, 2021 | -19.00M |
March 31, 2021 | -15.17M |
December 31, 2020 | -13.93M |
September 30, 2020 | -12.75M |
June 30, 2020 | -12.79M |
March 31, 2020 | -12.39M |
December 31, 2019 | -11.69M |
September 30, 2019 | -11.76M |
June 30, 2019 | -11.18M |
March 31, 2019 | -11.07M |
December 31, 2018 | -11.44M |
September 30, 2018 | -11.52M |
June 30, 2018 | -11.10M |
Date | Value |
---|---|
March 31, 2018 | -11.22M |
December 31, 2017 | -11.02M |
September 30, 2017 | -10.54M |
June 30, 2017 | -10.21M |
March 31, 2017 | -9.451M |
December 31, 2016 | -8.282M |
September 30, 2016 | -7.428M |
June 30, 2016 | -7.379M |
March 31, 2016 | -7.665M |
December 31, 2015 | -8.213M |
September 30, 2015 | -8.860M |
June 30, 2015 | -8.792M |
March 31, 2015 | -8.612M |
December 31, 2014 | -8.840M |
September 30, 2014 | -9.378M |
June 30, 2014 | -9.834M |
March 31, 2014 | -9.860M |
December 31, 2013 | -9.155M |
September 30, 2013 | -8.170M |
June 30, 2013 | -7.307M |
March 31, 2013 | -6.771M |
December 31, 2012 | -6.585M |
September 30, 2012 | -6.427M |
June 30, 2012 | -6.267M |
March 31, 2012 | -7.348M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-45.17M
Minimum
Jun 2024
-11.69M
Maximum
Dec 2019
-23.01M
Average
-22.32M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
Perspective Therapeutics Inc | -14.17M |
Actinium Pharmaceuticals Inc | -33.96M |
Chimerix Inc | -67.72M |
Marinus Pharmaceuticals Inc | -120.47M |
Jaguar Health Inc | -29.46M |